New immunotherapy cocktail takes on pancreatic cancer in phase 2 trial
NCT ID NCT04390399
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study tests whether adding an immunotherapy combination (aldoxorubicin, N-803, and PD-L1 t-haNK) to standard chemotherapy helps people with advanced pancreatic cancer live longer without their cancer growing. About 328 adults with locally advanced or metastatic pancreatic cancer are taking part. The goal is to see if the new combo improves outcomes like tumor shrinkage and quality of life compared to chemotherapy alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Astera Cancer Care
East Brunswick, New Jersey, 08816, United States
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105, United States
-
Chan Soon-Shiong Institute for Medicine
El Segundo, California, 90245, United States
-
Hoag memorial Presbyterian Hospital
Newport Beach, California, 92663, United States
Conditions
Explore the condition pages connected to this study.